News + Filings Holdings
All 13F 13D/G Other
|
BROOKSIDE CAPITAL PARTNERS FUND LP
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/24/2023 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
02/25/2022 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
02/17/2021 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
02/19/2020 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
05/15/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/21/2019 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
02/14/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
11/14/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
08/14/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
05/15/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/26/2018 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
02/14/2018 |
SC 13G/A
| BROOKSIDE CAPITAL PARTNERS FUND LP reports a 0% stake in Voyager Therapeutics, Inc. |
02/14/2018 |
SC 13G/A
| BROOKSIDE CAPITAL PARTNERS FUND LP reports a 0% stake in REGENXBIO Inc. |
02/14/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
11/14/2017 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
08/14/2017 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
05/15/2017 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice |
04/05/2017 |
4
| Bain Capital Public Equity Management, LLC (10% Owner) has filed a Form 4 on MULESOFT, INC
Txns:
| Sold 10,855 shares
@ $23.85, valued at
$258.9k
|
|
03/31/2017 |
4/A
| Bain Capital Public Equity Management, LLC (10% Owner) has filed a Form 4 on MULESOFT, INC
Txns:
| Bought 153,682 shares
@ $24.91, valued at
$3.8M
Bought 49,400 shares
@ $25.53, valued at
$1.3M
Sold 12,100 shares
@ $22.67, valued at
$274.3k
Sold 108,414 shares
@ $23.31, valued at
$2.5M
Sold 25,021 shares
@ $24, valued at
$600.5k
Sold 24,200 shares
@ $22.99, valued at
$556.4k
Sold 2,598 shares
@ $22.73, valued at
$59.1k
Sold 2,000 shares
@ $23.24, valued at
$46.5k
Sold 28,749 shares
@ $21.87, valued at
$628.7k
Sold 6,100 shares
@ $23.43, valued at
$142.9k
Sold 13,900 shares
@ $24.12, valued at
$335.3k
|
|
03/31/2017 |
3/A
| Bain Capital Public Equity Management, LLC (10% Owner) has filed a Form 3/A on MULESOFT, INC |
03/30/2017 |
4
| Bain Capital Public Equity Management, LLC (10% Owner) has filed a Form 4 on MULESOFT, INC
Txns:
| Bought 500,000 shares
@ $17, valued at
$8.5M
Bought 203,082 shares
@ $25.06, valued at
$5.1M
Converted 890,689 convertible preferred
@ $0 Converted 890,689 options to buy
@ $0 |
|
03/30/2017 |
3
| Bain Capital Public Equity Management, LLC (10% Owner) has filed a Form 3 on MULESOFT, INC |
02/23/2017 |
D/A
| Form D/A - Notice of Exempt Offering of Securities [Amend] |
02/14/2017 |
SC 13G/A
| BROOKSIDE CAPITAL PARTNERS FUND LP reports a 9.4% stake in REGENXBIO Inc. |
02/14/2017 |
SC 13G/A
| BROOKSIDE CAPITAL PARTNERS FUND LP reports a 4.1% stake in Radius Health, Inc. |
02/14/2017 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice |
11/14/2016 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice |
05/16/2016 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice |
02/16/2016 |
SC 13G/A
| BROOKSIDE CAPITAL PARTNERS FUND LP reports a 5% stake in Radius Health, Inc. |
02/16/2016 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice |
11/18/2015 |
SC 13G
| BROOKSIDE CAPITAL PARTNERS FUND LP reports a 5.9% stake in Voyager Therapeutics, Inc. |
10/22/2015 |
SC 13G
| BROOKSIDE CAPITAL PARTNERS FUND LP reports a 5% stake in Radius Health, Inc. |
09/30/2015 |
SC 13D/A
| BROOKSIDE CAPITAL PARTNERS FUND LP reports a 2% stake in Radius Health, Inc. |
09/24/2015 |
SC 13G
| BROOKSIDE CAPITAL PARTNERS FUND LP reports a 7.4% stake in REGENXBIO Inc. |
|
|
|